CYP 1.82% 27.0¢ cynata therapeutics limited

Takeover in 2019? Price?, page-102

  1. 587 Posts.
    lightbulb Created with Sketch. 212
    Whilst we can sit here all day comparing analysis on who's is "bigger", the fact is we are all here to make money at the end of the day, that is the ultimate goal otherwise why bother investing money.


    The potential for upside of CYP is greater, still with a high degree of risk, compared to MSB whereby the potential upside is maybe 2-3x ROI/~$2bn MCap with still a degree of risk.


    We are in the stage where MSB was 2009/2010, we are aiming for the highs of 2011 being 10x+ ROI, a game changer given many people on here have been long term investors that go back to the reverse takeover of ECQ..~$0.40. There is plenty of cash in the bank, low dilution, potential cash flow around the corner and a $bn partner who owns a small stake with a history of making T/O's.


    If your risk profile indicates this isn't a good investment for you, no problems, none of us are really bothered as it suits our risk profile regardless. Best thing to happen from this discussion is that we've gotten away from talking about directors loans and whatnot which is a breath of fresh air for this forum.

 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.